Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Effects Of Chromium Supplementation On Serum Glucose And Lipids In Patients With And Without Non-insulin-dependent Diabetes.

Abraham S. Abraham, B. A. Brooks, U. Eylath
Published 1992 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Seventy-six patients with established atherosclerotic disease were treated daily with either 250 micrograms of chromium orally as chromium chloride or a placebo for a period of 7 to 16 months (mean, 11.1 months). Serum chromium increased from 2.69 +/- 0.09 to 12.12 +/- 0.77 nmol/L (mean +/- SE, P less than .005). Serum triglycerides were lower (1.68 +/- 0.11 and 2.10 +/- 0.14 nmol/L, respectively; P less than .02) in the chromium-treated patients than in the patients who received placebo, and serum high-density lipoprotein (HDL) increased (from 0.94 +/- 0.05 to 1.14 +/- 0.07 mmol/L, P less than .005) in the patients who received chromium. There was no change in serum cholesterol or blood glucose during the study.
This paper references
10.1016/0026-0495(85)90151-9
Glucose tolerance and plasma lipid distributions in rats fed a high-sucrose, high-cholesterol, low-chromium diet.
D. Donaldson (1985)
10.1016/0009-8981(85)90183-4
Semi-automated determination of chromium in whole blood and serum by Zeeman electrothermal atomic absorption spectrophotometry.
A. J. Schermaier (1985)
10.1016/S0026-0495(85)80009-3
Diabetes, lipoproteins, and atherosclerosis.
G. Schonfeld (1985)
10.1093/jn/86.1.107
SOME ASPECTS OF GLUCOSE METABOLISM OF CHROMIUM-DEFICIENT RATS RAISED IN A STRICTLY CONTROLLED ENVIRONMENT.
W. Mertz (1965)
10.1159/000177646
Chromium and cholesterol-induced atherosclerosis in rabbits.
Abraham S. Abraham (1991)
10.1016/0021-9150(82)90149-6
The action of chromium on serum lipids and on atherosclerosis in cholesterol-fed rabbits.
Abraham S. Abraham (1982)
10.1152/AJPLEGACY.1959.196.3.614
Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets.
W. Mertz (1959)
10.1016/0026-0495(87)90206-X
Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia.
R. Anderson (1987)
Present knowledge of the role of chromium.
W. Mertz (1974)
10.1093/CLINCHEM/32.7.1350
Sampling and analysis techniques for monitoring serum for trace elements.
S. P. Ericson (1986)
The effect of prolonged treatment with differing doses of chromium on glucose homeostasis in rabbits.
M. Sonnenblick (1987)
10.1016/0026-0495(83)90203-2
Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables.
R. Anderson (1983)
10.2307/2332896
Nonparametric Statistics for the Behavioral Sciences.
F. N. David (1956)
10.1093/AJCN/42.3.454
The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects.
E. Offenbacher (1985)
10.1093/CLINCHEM/34.3.474
Trace elements in human clinical specimens: evaluation of literature data to identify reference values.
V. Iyengar (1988)
10.1001/JAMA.1978.03290190023013
Chromium supplementation and diabetes.
A. Wise (1978)
10.1093/AJCN/34.12.2670
Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men.
R. Riales (1981)
10.1093/AJCN/41.3.571
Serum chromium of human subjects: effects of chromium supplementation and glucose.
R. Anderson (1985)
10.1056/NEJM199011083231901
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
G. Brown (1990)
Glucokinase is not responsible for the anomeric specificity of glucose metabolism in pancreatic islets
W. Malaisse (1985)
10.1093/CLINCHEM/18.6.499
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
W. Friedewald (1972)
10.2337/diab.29.11.919
Beneficial Effect of Chromium-rich Yeast on Glucose Tolerance and Blood Lipids in Elderly Subjects
E. Offenbacher (1980)
10.1093/AJCN/38.3.404
Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics.
M. Uusitupa (1983)
10.1093/CLINCHEM/24.4.541
Serum chromium and angiographically determined coronary artery disease.
H. Newman (1978)



This paper is referenced by
10.13181/MJI.V7I1.795
Effect of chromium supplementation on chromium status, insulin and glucose level in Non-insulin Dependent Diabetes Mellitus (NIDDM) subjects
Murjiah Dinarto (1998)
10.1385/BTER:98:2:159
Absorption of the biomimetic chromium cation triaqua-μ3-oxo-μ-hexapropionatotrichromium(III) in rats
Buffie J. Clodfelder (2007)
Effect of chromium supplementation on glucose tolerance and lipid profile.
S. Bahijri (2000)
Untersuchungen zur Bioverfügbarkeit von Chrom aus Nahrungsergänzungsmitteln. Aufnahme, Metabolismus und Ausscheidung von 51 Cr in der Ratte
Experimentelle Medizin (2010)
10.2165/00024677-200403010-00005
The Role of Antioxidant Micronutrients in the Prevention of Diabetic Complications
D. Bonnefont‐Rousselot (2004)
10.1111/J.1753-4887.1998.TB01664.X
Is chromium supplementation effective in managing type II diabetes?
M. Hellerstein (1998)
10.1186/1475-2891-14-14
Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
R. V. Yin (2015)
10.1007/s12011-011-9234-3
Chromium Supplementation Can Alleviate the Negative Effects of Heat Stress on Growth Performance, Carcass Traits, and Meat Lipid Oxidation of Broiler Chicks without Any Adverse Impacts on Blood Constituents
M. Toghyani (2011)
Chromium (III) Picolinate- A Review
Karnakumar V. Biradar (2012)
10.1111/jcpt.12147
Systematic review and meta‐analysis of the efficacy and safety of chromium supplementation in diabetes
N. Suksomboon (2014)
The Effect of Exercise, Reflexology and Chrome on Metabolic Syndrome
F. Arslan (2018)
10.1016/S0946-672X(04)80025-7
Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats.
Dong-sun Kim (2004)
10.2527/1999.7751284X
Dietary protein and chromium tripicolinate in Suffolk wether lambs: effects on production characteristics, metabolic and hormonal responses, and immune status.
L. R. Gentry (1999)
Determination of Macro and Micro Elements in Some Selected Anti-diabetic Medicinal Plants in Adamawa State, Nigeria Using Instrumental Neutron Analysis
T. S. Magili (2018)
10.1016/B978-044453071-4/50002-3
Introduction: A history of chromium studies (1955–1995)
J. Vincent (2007)
10.1016/S0955-2863(98)00043-6
Combined dietary chromium picolinate supplementation and an exercise program leads to a reduction of serum cholesterol and insulin in college-aged subjects
S. Boyd (1998)
10.1515/JLM.2006.031
Bedeutung von Chrom, Kupfer, Selen und Zink bei Diabetes mellitus Typ 1 und Typ 2 mit Folgeerkrankungen / Importance of chromium, copper, selenium and zinc in diabetes mellitus type 1 and type 2 with late disease
M. Rükgauer (2006)
Effet du chrome niacinate sur la tolérance au glucose chez le rat Wistar
H. Oueslati (2013)
10.1097/00005768-199708000-00003
Chromium and exercise training: effect on obese women.
K. E. Grant (1997)
10.7897/2277-4572.034160
EVIDENCE FOR USE OF CHROMIUM IN TREATMENT OF PRE-DIABETES
Nicholas J. D. Wright (2014)
10.1007/s12011-008-8124-9
Effects of Pre- and Postnatal Exposure to Chromium Picolinate or Picolinic Acid on Neurological Development in CD-1 Mice
M. Bailey (2008)
10.1345/aph.1C304
Chromium as Adjunctive Treatment for Type 2 Diabetes
G. Ryan (2003)
10.1080/07315724.2001.10719050
Effect of Chromium Supplementation and Exercise on Body Composition, Resting Metabolic Rate and Selected Biochemical Parameters in Moderately Obese Women Following an Exercise Program
S. Volpe (2001)
10.1016/S0271-5317(98)00084-0
Effects of dietary chromium, copper and zinc on plasma lipid concentrations in male Japanese quail
J. Hermann (1998)
10.1093/AJCN/73.1.99
Serum chromium does not predict glucose tolerance in late pregnancy.
J. Gunton (2001)
Diabetes prevention and management: the role of trace minerals
I. K. Akhuemokhan (2013)
10.1007/s11010-008-9744-2
Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes
F. C. Lau (2008)
10.1007/s12011-013-9863-9
Improved Meta-Analytic Methods Show No Effect of Chromium Supplements on Fasting Glucose
C. H. Bailey (2013)
10.1016/j.jpedsurg.2012.01.015
Role of trace elements in parenteral nutrition support of the surgical neonate.
S. Burjonrappa (2012)
10.1016/S0026-0495(97)90179-7
Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type II diabetes mellitus.
S. Davies (1997)
10.1006/ABBI.1997.9878
Isolation and characterization of a biologically active chromium oligopeptide from bovine liver.
C. M. Davis (1997)
10.1038/srep15606
Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study
J. Bai (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar